1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 13 OCTOBER 2014

CNS Drug News 13 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Progressive MS Pipeline To See Increased Activity
Industry Brief - Bayer Comments On NICE Guideline Regarding MS Management
Industry Brief - Synthon Files Glatiramer ANDA With FDA
Industry Brief - FDA Grants Fast Track Designation To NurOwn For ALS
Industry Brief - Reata Initiates RTA 408 Phase II Studies In FA/Mitochondrial Myopathies
Industry Brief - Horizon Receives FDA ODD For Actimmune In FA
Industry Brief - Data Presented From Actimmune Phase II Study In FA
Industry Brief - StemCells Initiates Phase II Trial In Cervical SCI
Industry Brief - Stemedica Secures US Patent To Use Multiple SC Lines Simultaneously For Ischaemic Stroke
Industry Brief - NeurOp Receives Milestone As BMS Nominates Compound
Industry Brief - Alcobra Reports Top-Line Results From MDX Phase III Study In Adult ADHD
Industry Brief - Neos Issued Key Patent Covering XR-ODT Platform Technology
Industry Brief - Zogenix Submits sNDA For Modified Formulation Of Zohydro ER
Industry Trend Analysis - Teva Behind In Abuse-Deterrent Hydrocodone ER Race
Industry Brief - Purdue Commercially Launches New Dosage Strength Of Butrans
Industry Brief - Trevena Completes Enrolment Of TRV130 Phase IIa/b Study Ahead Of Schedule
Industry Brief - IntelGenx/RedHill Submit European MAA For Rizaport
Industry Brief - Eisai Names Partner For Pan Middle-East Distribution Of Fycompa
Industry Brief - New Generic Threat To Trokendi XR Revealed
Industry Brief - French Transparency Commission Recognises Efficacy Of Zonegran MT
Industry Brief - Supernus Files Topiramate Lawsuit Against Actavis
Industry Trend Analysis - Akynzeo To Compete With Merck's Emend In CINV Prevention
Industry Brief - Acacia Reports Positive Phase III Results For APD421 In PONV
Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory
Industry Brief - CNS Conferences - January 2015

Table Of Contents

CNS Drug News 13 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.